Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

NCT00896792 | Completed Early Phase 1 DMC

• 4 other identifiers: CDR0000615562P30CA015083MC089208-002293
• Study Type: interventional
• Target: 26
• Locations: 1 country
• Sites: 1

Brief Summary

RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.

Conditions

Hematopoietic/Lymphoid Cancer; Unspecified Adult Solid Tumor, Protocol Specific

Keywords

unspecified adult solid tumor, protocol specific; hematopoietic/lymphoid cancer

Outcome Measures

Primary Outcomes (1)

• Increased length of enrollment time in hospice care

Secondary Outcomes (3)

• Effects of incorporating a palliative care advanced registered nurse practitioner liaison program in the late-stage cancer care process

• Increased knowledge of hospice services as assessed by a knowledge survey

• Patient and family or caregiver psychological stress, as measured by the functional assessment of cancer therapy general (FACT-G) survey

Interventions

counseling intervention OTHER

questionnaire administration OTHER

survey administration OTHER

end-of-life treatment/management PROCEDURE

psychosocial assessment and care PROCEDURE

Eligibility Criteria

• Age: 18 Years - 120 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

DISEASE CHARACTERISTICS: * Diagnosis of terminal metastatic cancer * Patient at Mayo Clinic in Jacksonville, Florida * Strong candidate for hospice care * Entering or planning to enter Community Hospice of Northeast Florida * Willing to undergo visits by an Advanced Registered Nurse Practitioner (ARNP) after hospice enrollment PATIENT CHARACTERISTICS: * Willing to participate in 2 palliative care consultations with an ARNP prior to hospice enrollment * Life expectancy \< 12 months * Able to complete questionnaires with or without assistance * Has a primary caregiver with an identified relationship to the patient PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Mayo Clinic: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Mayo Clinic in Jacksonville

Jacksonville, Florida, 32224, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

Counseling; Therapeutics; Psychiatric Rehabilitation

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Mental Health Services; Behavioral Disciplines and Activities; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Rehabilitation

Study Officials

• Gerardo Colon-Otero, M.D.

  Mayo Clinic

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: early phase 1
• Allocation: NA
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 9, 2009
• First Posted: May 12, 2009
• Study Start: October 10, 2008
• Primary Completion: November 20, 2009
• Study Completion: March 17, 2015
• Last Updated: October 9, 2018

Record last verified: 2018-10

Locations

US (1)